VIKING THERAPEUTICS INC (VKTX:NASDAQ)
$34.26 -0.69 (-1.9742%)
Analysed VIKING THERAPEUTICS INC (VKTX:NASDAQ) News Sources
Is It Too Early To Consider Viking Therapeutics (VKTX) A Bargain After Recent Pullback?
12-04-2026
yahoo.com
Viking Therapeutics (VKTX) Barely Up Since Jim Cramer Advised Selling The Stock
11-04-2026
yahoo.com
LLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships
10-04-2026
yahoo.com
Who Benefits From Amazon Pharmacy Stocking Eli Lilly’s New Weight Loss Pill
10-04-2026
247wallst.com
Viking Therapeutics to Participate at Upcoming Investor Conferences
10-04-2026
yahoo.com
Viking Therapeutics May Benefit From New Era for Weight Loss Pills, Oppenheimer Says
08-04-2026
yahoo.com
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts
06-04-2026
yahoo.com
How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval
06-04-2026
yahoo.com
Where Will Viking Therapeutics Stock Be in 10 Years?
03-04-2026
fool.com
Did VK2735’s VANQUISH-2 Enrollment Milestone Just Reframe Viking Therapeutics' (VKTX) Obesity Drug Ambitions?
03-04-2026
yahoo.com
What is the current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ) is $34.26.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is $-0.69.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is -1.9742%.
What is the most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is .
SEC-8K** Filing Available For VIKING THERAPEUTICS INC (VKTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.